Secondary acute myeloid leukemia with translocation (4;11) and MLL/AF4 rearrangement in a 15-year-old boy treated for common acute lymphoblastic leukemia 11 years earlier

Ann Hematol. 1995 Jan;70(1):31-5. doi: 10.1007/BF01715379.

Abstract

Secondary acute myeloid leukemia occurring in a 15-year-old boy 11 years after initial treatment of a common lymphoblastic leukemia (c-ALL) is described. Initial complete remission was terminated after 4 years by an isolated testicular relapse, followed by first bone marrow relapse within 18 months. After he achieved remission again, an allogeneic bone marrow transplantation from his HLA-identical brother was performed. Five years and 9 months later, the patient developed thrombocytopenia, leukopenia, and anemia, but bone marrow biopsies at this time demonstrated only myelofibrosis, with no blast cell population present. A polymerase chain reaction assay of a peripheral blood sample recognized the mRNA fusion region for the MLL/AF4 rearrangement, i.e., the molecular equivalent of the translocation (4;11)(q21,q23). Four weeks later, a blast cell population with AML-M1 morphology according to the FAB classification appeared in the bone marrow, and translocation (4;11) was detected by cytogenetics. Thus, secondary leukemias with chromosomal 11q23 rearrangement can develop after a long latency period and can be diagnosed earlier with the PCR technique.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Bone Marrow / pathology
  • Bone Marrow Transplantation
  • Chromosomes, Human, Pair 11
  • Chromosomes, Human, Pair 4
  • DNA, Neoplasm / genetics
  • DNA-Binding Proteins / genetics*
  • Gene Rearrangement*
  • Histone-Lysine N-Methyltransferase
  • Humans
  • Leukemia, Myeloid / diagnosis
  • Leukemia, Myeloid / etiology*
  • Leukemia, Myeloid / genetics
  • Male
  • Myeloid-Lymphoid Leukemia Protein
  • Nuclear Proteins / genetics
  • Polymerase Chain Reaction
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy
  • Proto-Oncogenes*
  • RNA, Messenger / genetics
  • Transcription Factors*
  • Transcriptional Elongation Factors
  • Translocation, Genetic*
  • Transplantation, Homologous

Substances

  • DNA, Neoplasm
  • DNA-Binding Proteins
  • KMT2A protein, human
  • Nuclear Proteins
  • RNA, Messenger
  • Transcription Factors
  • Transcriptional Elongation Factors
  • Myeloid-Lymphoid Leukemia Protein
  • AFF1 protein, human
  • Histone-Lysine N-Methyltransferase